Compared with the control group , the VAS score of the experimental group had an obviously reduction ( F = 98.138 , P < 0.01 ) after treatment ; the hip BMD value at 3 months after treatment in the experimental group was higher than that of the control group ( P < 0.05 ) ; the fracture healing rate of the experimental group was higher than that of the control group ( P < 0.05 ) ; Harris score in 3 months of follow-up in the experimental group was higher than that of the control group ( t = 2.542 , P < 0.05 ) ; all the differences between two groups were statistically significant ( P < 0.05 ) .